← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

EXPO logoExponent, Inc.(EXPO)Earnings, Financials & Key Ratios

EXPO•NASDAQ
$64.21
$3.16B mkt cap·31.0× P/E·Price updated May 6, 2026
SectorIndustrialsIndustryConsulting ServicesSub-IndustryTechnical and engineering consulting
AboutExponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.Show more
  • Revenue$582M+4.2%
  • EBITDA$130M+0.5%
  • Net Income$106M-2.7%
  • EPS (Diluted)2.07-1.9%
  • Gross Margin24.97%-2.0%
  • EBITDA Margin22.31%-3.6%
  • Operating Margin20.58%-3.9%
  • Net Margin18.21%-6.7%
  • ROE26.13%-6.9%
  • ROIC36.31%-10.8%
  • Debt/Equity0.21+9.7%
Technical→

EXPO Key Insights

Exponent, Inc. (EXPO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 27.9%
  • ✓FCF machine: 21.0% free cash flow margin
  • ✓13 consecutive years of dividend growth
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy 5Y average net margin of 19.6%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

EXPO Price & Volume

Exponent, Inc. (EXPO) stock price & volume — 10-year historical chart

Loading chart...

EXPO Growth Metrics

Exponent, Inc. (EXPO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.41%
5 Years7.79%
3 Years4.28%
TTM5.67%

Profit CAGR

10 Years9.29%
5 Years5.13%
3 Years1.18%
TTM-2.75%

EPS CAGR

10 Years9.97%
5 Years5.96%
3 Years1.84%
TTM-1.89%

Return on Capital

10 Years22.23%
5 Years23.29%
3 Years21.8%
Last Year19.25%

EXPO Recent Earnings

Exponent, Inc. (EXPO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 12/12 qtrs (100%)
Q2 2026Latest
Apr 30, 2026
EPS
$0.59
Est $0.56
+5.4%
Revenue
$152M
Est $150M
+1.5%
Q1 2026
Feb 5, 2026
EPS
$0.49
Est $0.47
+4.3%
Revenue
$129M
Est $128M
+1.0%
Q4 2025
Oct 30, 2025
EPS
$0.55
Est $0.50
+10.0%
Revenue
$147M
Est $128M
+14.5%
Q3 2025
Jul 31, 2025
EPS
$0.52
Est $0.48
+8.3%
Revenue
$142M
Est $132M
+7.5%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$0.59vs $0.56+5.4%
$152Mvs $150M+1.5%
Q1 2026Feb 5, 2026
$0.49vs $0.47+4.3%
$129Mvs $128M+1.0%
Q4 2025Oct 30, 2025
$0.55vs $0.50+10.0%
$147Mvs $128M+14.5%
Q3 2025Jul 31, 2025
$0.52vs $0.48+8.3%
$142Mvs $132M+7.5%
Based on last 12 quarters of dataView full earnings history →

EXPO Peer Comparison

Exponent, Inc. (EXPO) competitors in Technical and engineering consulting — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ICFI logoICFIICF International, Inc.Direct Competitor1.33B73.5814.86-7.27%4.89%9.11%0.56
CRAI logoCRAICRA International, Inc.Direct Competitor999.4M152.6418.759.33%7.29%25.65%0.36
HCI logoHCIHCI Group, Inc.Direct Competitor2B154.146.2020.21%33.16%36.22%0.06
FORR logoFORRForrester Research, Inc.Direct Competitor116.78M6.09-0.97-8.23%-30.07%-80.76%0.57
FCN logoFCNFTI Consulting, Inc.Product Competitor4.85B160.9919.542.44%6.88%15.14%0.34
VRSK logoVRSKVerisk Analytics, Inc.Product Competitor22.39B170.8926.336.63%29.34%437.95%16.26
EFX logoEFXEquifax Inc.Product Competitor20.89B173.2032.566.92%11.12%14.19%1.07
ACN logoACNAccenture plcSupply Chain108.69B174.5714.377.36%10.65%23.92%0.25

Compare EXPO vs Peers

Exponent, Inc. (EXPO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ICFI

Most directly comparable listed peer for EXPO.

Scale Benchmark

vs ACN

Larger-name benchmark to compare EXPO against a more recognizable public peer.

Peer Set

Compare Top 5

vs ICFI, CRAI, HCI, FORR

EXPO Income Statement

Exponent, Inc. (EXPO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Jan'20Jan'21Dec'21Dec'22Dec'23Jan'25Jan'26
Sales/Revenue347.8M379.52M417.2M399.9M466.27M513.29M536.77M558.51M582.01M
Revenue Growth %10.39%9.12%9.93%-4.15%16.6%10.09%4.57%4.05%4.21%
Cost of Goods Sold18.14M24.88M25.81M303.76M342.06M348.79M401M416.23M436.71M
COGS % of Revenue5.21%6.56%6.19%75.96%73.36%67.95%74.71%74.52%75.03%
Gross Profit
329.66M▲ 0%
354.64M▲ 7.6%
391.39M▲ 10.4%
96.14M▼ 75.4%
124.21M▲ 29.2%
164.5M▲ 32.4%
135.76M▼ 17.5%
142.28M▲ 4.8%
145.31M▲ 2.1%
Gross Margin %94.79%93.44%93.81%24.04%26.64%32.05%25.29%25.48%24.97%
Gross Profit Growth %10.18%7.58%10.36%-75.44%29.2%32.44%-17.47%4.8%2.13%
Operating Expenses275.75M288.07M306.28M12.89M15.28M23.66M24.44M22.73M25.52M
OpEx % of Revenue79.28%75.9%73.41%3.22%3.28%4.61%4.55%4.07%4.38%
Selling, General & Admin228.07M232.58M272.72M262.93M293.33M287.89M24.44M22.73M25.52M
SG&A % of Revenue65.57%61.28%65.37%65.75%62.91%56.09%4.55%4.07%4.38%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses9.16M-890K33.56M-250.04M-278.05M-264.24M000
Operating Income
72.05M▲ 0%
91.46M▲ 26.9%
85.11M▼ 6.9%
83.25M▼ 2.2%
108.93M▲ 30.8%
140.84M▲ 29.3%
111.32M▼ 21.0%
119.56M▲ 7.4%
119.79M▲ 0.2%
Operating Margin %20.72%24.1%20.4%20.82%23.36%27.44%20.74%21.41%20.58%
Operating Income Growth %16.38%26.93%-6.94%-2.19%30.84%29.3%-20.96%7.4%0.19%
EBITDA78.34M97.75M91.92M90.12M115.41M147.92M120.24M129.25M129.87M
EBITDA Margin %22.52%25.76%22.03%22.54%24.75%28.82%22.4%23.14%22.31%
EBITDA Growth %15.13%24.78%-5.97%-1.96%28.07%28.17%-18.71%7.49%0.48%
D&A (Non-Cash Add-back)6.29M6.29M6.81M6.87M6.49M7.08M8.92M9.69M10.08M
EBIT72.05M91.46M85.11M83.25M108.93M140.84M111.32M119.56M147.3M
Net Interest Income1.29M2.75M3.91M1.71M66K2.1M7.15M10M9.31M
Interest Income1.29M2.75M3.91M1.71M66K2.1M7.15M10M9.31M
Interest Expense000000000
Other Income/Expense10.46M1.86M19.08M13.69M16.91M-8.61M24.57M27.81M27.51M
Pretax Income
82.51M▲ 0%
93.32M▲ 13.1%
104.19M▲ 11.7%
96.94M▼ 7.0%
125.84M▲ 29.8%
132.23M▲ 5.1%
135.9M▲ 2.8%
147.37M▲ 8.4%
147.3M▼ 0.0%
Pretax Margin %23.72%24.59%24.97%24.24%26.99%25.76%25.32%26.39%25.31%
Income Tax41.2M21.06M21.73M14.38M24.64M29.9M35.56M38.37M41.29M
Effective Tax Rate %49.94%22.57%20.86%14.84%19.58%22.61%26.16%26.04%28.03%
Net Income
41.3M▲ 0%
72.25M▲ 74.9%
82.46M▲ 14.1%
82.55M▲ 0.1%
101.2M▲ 22.6%
102.33M▲ 1.1%
100.34M▼ 1.9%
109M▲ 8.6%
106.01M▼ 2.7%
Net Margin %11.88%19.04%19.77%20.64%21.7%19.94%18.69%19.52%18.21%
Net Income Growth %-13.01%74.93%14.13%0.11%22.59%1.11%-1.95%8.63%-2.75%
Net Income (Continuing)41.3M72.25M82.46M82.55M101.2M102.33M100.34M109M106.01M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
0.77▲ 0%
1.33▲ 72.7%
1.53▲ 15.0%
1.55▲ 1.3%
1.90▲ 22.6%
1.96▲ 3.2%
1.94▼ 1.0%
2.11▲ 8.8%
2.07▼ 1.9%
EPS Growth %-11.49%72.73%15.04%1.31%22.58%3.16%-1.02%8.76%-1.9%
EPS (Basic)0.781.371.571.581.921.981.962.132.08
Diluted Shares Outstanding53.97M54.17M53.88M53.32M53.33M52.28M51.63M51.57M51.24M
Basic Shares Outstanding52.72M52.91M52.69M52.39M52.61M51.73M51.15M51.13M50.9M
Dividend Payout Ratio52.86%37.67%40.63%48.18%42.68%48.12%53.86%53.41%58.05%

EXPO Balance Sheet

Exponent, Inc. (EXPO) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Jan'20Jan'21Dec'21Dec'22Dec'23Jan'25Jan'26
Total Current Assets315.51M326.61M364.04M366.83M452.76M349.16M379.53M446.88M427.58M
Cash & Short-Term Investments196.4M208.55M231.6M242.53M297.69M161.46M187.15M258.9M221.93M
Cash Only124.79M127.06M176.44M197.53M297.69M161.46M187.15M258.9M221.93M
Short-Term Investments71.6M81.5M55.16M45M00000
Accounts Receivable110.1M105.81M120.14M111.56M139.86M170.11M167.36M161.41M181.51M
Days Sales Outstanding115.55101.76105.11101.83109.48120.97113.8105.48113.83
Inventory000000000
Days Inventory Outstanding---------
Other Current Assets9.01M12.24M7.53M12.74M017.59M25.02M26.57M24.14M
Total Non-Current Assets124.08M142.32M199.37M226.94M230.98M237.5M267.25M330.39M381.04M
Property, Plant & Equipment35.01M46.1M84.59M79.14M74.34M83.55M99.92M148.25M145.36M
Fixed Asset Turnover9.93x8.23x4.93x5.05x6.27x6.14x5.37x3.77x4.00x
Goodwill8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M8.61M
Intangible Assets000000000
Long-Term Investments-30.44M-34.09M-36.82M000000
Other Non-Current Assets80.46M87.61M106.17M84.97M101.48M91.44M104.9M116.4M128.9M
Total Assets
439.59M▲ 0%
468.94M▲ 6.7%
563.41M▲ 20.1%
593.77M▲ 5.4%
683.74M▲ 15.2%
586.66M▼ 14.2%
646.78M▲ 10.2%
777.27M▲ 20.2%
808.62M▲ 4.0%
Asset Turnover0.79x0.81x0.74x0.67x0.68x0.87x0.83x0.72x0.72x
Asset Growth %8.88%6.68%20.15%5.39%15.15%-14.2%10.25%20.18%4.03%
Total Current Liabilities93.11M98.3M123.96M117.31M152.98M159.03M161.91M163.18M178M
Accounts Payable2.78M2.55M4.64M3.28M3.19M8.64M4.49M5.27M6.87M
Days Payables Outstanding56.0337.4265.683.943.419.044.094.625.75
Short-Term Debt005.94M5.99M00006.89M
Deferred Revenue (Current)8.3M9.17M12.71M11.8M19.76M18.83M21.71M16.37M18.87M
Other Current Liabilities00013.05M9.38M10.17M13.17M14.98M24.07M
Current Ratio3.39x3.32x2.94x3.13x2.96x2.20x2.34x2.74x2.40x
Quick Ratio3.39x3.32x2.94x3.13x2.96x2.20x2.34x2.74x2.40x
Cash Conversion Cycle---------
Total Non-Current Liabilities57.39M56.72M89.2M114.97M113.69M106.88M128.78M193.02M240.27M
Long-Term Debt000000000
Capital Lease Obligations0018.16M14.34M9.81M13.34M21.96M76.08M75.94M
Deferred Tax Liabilities5.51M3.36M14.17M13.68M000031.1M
Other Non-Current Liabilities57.39M56.72M71.04M86.95M103.89M93.54M106.82M116.94M133.23M
Total Liabilities150.5M155.03M213.16M232.28M266.67M265.91M290.69M356.2M418.27M
Total Debt0024.1M20.33M14.97M18.6M28.26M81.48M82.83M
Net Debt-124.79M-127.06M-152.33M-177.19M-282.72M-142.86M-158.89M-177.42M-139.1M
Debt / Equity--0.07x0.06x0.04x0.06x0.08x0.19x0.21x
Debt / EBITDA--0.26x0.23x0.13x0.13x0.24x0.63x0.64x
Net Debt / EBITDA-1.59x-1.30x-1.66x-1.97x-2.45x-0.97x-1.32x-1.37x-1.07x
Interest Coverage---------
Total Equity
289.09M▲ 0%
313.91M▲ 8.6%
350.25M▲ 11.6%
361.5M▲ 3.2%
417.06M▲ 15.4%
320.75M▼ 23.1%
356.08M▲ 11.0%
421.07M▲ 18.2%
390.34M▼ 7.3%
Equity Growth %5.76%8.59%11.58%3.21%15.37%-23.09%11.02%18.25%-7.3%
Book Value per Share5.365.806.506.787.826.146.908.177.62
Total Shareholders' Equity289.09M313.91M350.25M361.5M417.06M320.75M356.08M421.07M390.34M
Common Stock33K66K66K66K66K66K66K66K66K
Retained Earnings303.99M342.02M384.67M421.81M478.37M528.81M574.08M624.15M668.42M
Treasury Stock-223.17M-252.61M-277.66M-323.77M-340.81M-505.54M-536.53M-545.05M-645.61M
Accumulated OCI-2.03M-2.85M-1.76M-1.93M-1.98M-3.59M-2.98M-3.79M-2.29M
Minority Interest000000000

EXPO Cash Flow Statement

Exponent, Inc. (EXPO) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Jan'20Jan'21Dec'21Dec'22Dec'23Jan'25Jan'26
Cash from Operations67.84M91.19M108.06M103.31M124.57M93.81M127.35M144.54M131.73M
Operating CF Margin %19.5%24.03%25.9%25.83%26.72%18.28%23.73%25.88%22.63%
Operating CF Growth %1.33%34.42%18.5%-4.39%20.57%-24.69%35.76%13.49%-8.86%
Net Income41.3M72.25M82.46M82.55M101.2M102.33M100.34M109M106.01M
Depreciation & Amortization6.29M6.29M6.81M6.87M6.49M7.08M8.92M9.69M10.08M
Stock-Based Compensation16.16M16.99M17.47M17.28M19.26M20.36M20.36M23.24M23.8M
Deferred Taxes11.79M-3.71M-2.85M-3.64M-6M-7.36M85K-3.3M-9.95M
Other Non-Cash Items2.14M1.91M1.71M1.69M1.95M3.08M3.23M4.45M2.99M
Working Capital Changes-9.84M-2.54M2.46M-1.44M1.67M-31.68M-5.57M1.46M-1.2M
Change in Receivables-25.2M2.44M-16.55M6.72M-30.25M-33.33M-471K1.5M-23.09M
Change in Inventory8.7M-1.23M8.55M000000
Change in Payables5.98M-4.62M6.71M-2.65M8.44M2.21M-5.05M436K7.68M
Cash from Investing-17.72M-25.82M4.27M5.02M38.18M-12.04M-16.36M-6.94M-9.39M
Capital Expenditures-4.72M-16.3M-23.04M-4.99M-6.83M-12.04M-16.36M-6.94M-9.39M
CapEx % of Revenue1.36%4.29%5.52%1.25%1.46%2.35%3.05%1.24%1.61%
Acquisitions0023.04M000000
Investments---------
Other Investing-13M-9.52M-23.04M000000
Cash from Financing-41.26M-62.5M-63.41M-88.36M-62.75M-215.98M-86.01M-65.11M-160.43M
Debt Issued (Net)000000000
Equity Issued (Net)-11.93M-27.91M-18.73M-40.05M-7M-153.84M-22.02M-5.71M-94.72M
Dividends Paid-21.84M-27.22M-33.5M-39.77M-43.2M-49.24M-54.04M-58.21M-61.54M
Share Repurchases-11.93M-27.91M-21.96M-40.05M-7M-155.86M-24.21M-5.71M-97.09M
Other Financing-7.5M-7.37M-11.18M-8.53M-12.55M-12.9M-9.94M-1.18M-4.17M
Net Change in Cash
9.83M▲ 0%
2.27M▼ 77.0%
49.38M▲ 2080.0%
21.09M▼ 57.3%
100.16M▲ 374.9%
-136.23M▼ 236.0%
25.69M▲ 118.9%
71.75M▲ 179.3%
-36.97M▼ 151.5%
Free Cash Flow
63.11M▲ 0%
74.89M▲ 18.7%
85.02M▲ 13.5%
98.33M▲ 15.6%
117.74M▲ 19.7%
81.76M▼ 30.6%
111M▲ 35.8%
137.6M▲ 24.0%
122.34M▼ 11.1%
FCF Margin %18.15%19.73%20.38%24.59%25.25%15.93%20.68%24.64%21.02%
FCF Growth %20.09%18.66%13.53%15.65%19.75%-30.56%35.75%23.97%-11.09%
FCF per Share1.171.381.581.842.211.562.152.672.39
FCF Conversion (FCF/Net Income)1.64x1.26x1.31x1.25x1.23x0.92x1.27x1.33x1.24x
Interest Paid000000000
Taxes Paid25.85M28.64M020.12M27.91M40.12M38.94M00

EXPO Key Ratios

Exponent, Inc. (EXPO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)17.71%14.69%23.96%24.83%23.2%26%27.74%29.65%28.05%26.13%
Return on Invested Capital (ROIC)31.43%33.49%39.07%33.18%32.67%51.28%67.66%44.52%40.68%36.31%
Gross Margin94.96%94.79%93.44%93.81%24.04%26.64%32.05%25.29%25.48%24.97%
Net Margin15.07%11.88%19.04%19.77%20.64%21.7%19.94%18.69%19.52%18.21%
Debt / Equity---0.07x0.06x0.04x0.06x0.08x0.19x0.21x
FCF Conversion1.41x1.64x1.26x1.31x1.25x1.23x0.92x1.27x1.33x1.24x
Revenue Growth0.72%10.39%9.12%9.93%-4.15%16.6%10.09%4.57%4.05%4.21%

EXPO SEC Filings & Documents

Exponent, Inc. (EXPO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Apr 6, 2026·SEC

Material company update

Feb 5, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 23, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 8, 2025·SEC

FY 2025

May 9, 2025·SEC

EXPO Frequently Asked Questions

Exponent, Inc. (EXPO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Exponent, Inc. (EXPO) reported $582.0M in revenue for fiscal year 2025. This represents a 892% increase from $58.7M in 1996.

Exponent, Inc. (EXPO) grew revenue by 4.2% over the past year. Growth has been modest.

Yes, Exponent, Inc. (EXPO) is profitable, generating $106.0M in net income for fiscal year 2025 (18.2% net margin).

Dividend & Returns

Yes, Exponent, Inc. (EXPO) pays a dividend with a yield of 1.87%. This makes it attractive for income-focused investors.

Exponent, Inc. (EXPO) has a return on equity (ROE) of 26.1%. This is excellent, indicating efficient use of shareholder capital.

Exponent, Inc. (EXPO) generated $122.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More EXPO

Exponent, Inc. (EXPO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.